InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,618.80
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.58
(
-0.35%
)
Bitcoin
62,615.20
(
0.45%
)
Post# of 54592
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

02opida

Send PM Follow Ignore
Followers 1169
Posts 168505
Boards Moderated 5
Alias Born 12/20/2003

02opida

Member Level

Re: None

Monday, 03/19/2018 9:24:31 AM

Monday, March 19, 2018 9:24:31 AM

Post# of 54592
ETBI ~ The company has developed a cost effective insulin mouth rinse that can treat the diabetes epidemic in the emerging markets starting in the Philippines. Large drug manufactures like Novo Nordisk (NYSE: NVO) with its complete line of diabetes drugs doesn’t have anything like it. Most of the other big drug makers like Eli Lily (NYSE: LLY), AstraZeneca (NYSE: AZN), and Sanofi Adventis (NYSE: SNY) have injection type drugs that take a sick pancreas and try to squeeze as much insulin output as they can so that the diabetes patient only has to take one shot a week

History.htm

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up